COVID-19 and MS: Global Data Sharing Initiative
MS data sharing during the coronavirus pandemic.
Research
High-dose biotin trial produces disappointing results
This week, MedDay Pharmaceuticals announced that the second pivotal Phase 3 trial (SPI2) of MD1003 (biotin), an investigational product for primary and secondary progressive MS has failed to meet its primary and secondary endpoints.
MS Index highlights severe lack of specialist healthcare services for people living with MS in Ireland
The Futureproofing Healthcare MS Index focuses on the treatment of MS across 30 European countries, with Ireland ranking in bottom third overall
NUI Galway Call For Participates - COB-MS
A cognitive occupation-based programme for people with multiple sclerosis: A randomised controlled pilot trial to improve cognition and daily functioning for people with multiple sclerosis.
New Research Study
Bladder dysfunction and management strategies among people with Multiple sclerosis (MS): a qualitative study of people with MS perspectives
Watch Annual Conference From AnyWhere Around the World
MS talks at the 2019 Annual Conference in Limerick
European Disability Strategy Consultation
The European Commission is hosting a survey consultation on the current European Disability Strategy
EMA warns that Gilenya must not be used during pregnancy
The European Medicines Agency has issued a press release recommending that Gilenya (fingolimod) not be used during pregnancy or by women of child-baring age who are not using effective contraception.